Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: A prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut)

Gynecologic Malignancies ◽

Prospective Phase

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group

British Journal of Cancer ◽

10.1038/sj.bjc.6603787 ◽

2007 ◽

Vol 96 (11) ◽

pp. 1639-1643 ◽

Cited By ~ 25

Author(s):

S Pignata ◽

G Scambia ◽

C Pisano ◽

E Breda ◽

M Di Maio ◽

...

Keyword(s):

Ovarian Cancer ◽

Endometrial Carcinoma ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Gynecologic Malignancies ◽

First Line ◽

Multicentre Phase ◽

Line Chemotherapy

Phase II study of combination therapy with pegylated liposomal doxorubicin (PLD)and carboplatin in patients (pts) with relapsed, platinum sensitive and platinum semi-sensitive ovarian cancer

10.1200/jco.2008.26.15_suppl.5555 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5555-5555

Author(s):

B. L. Rapoport ◽

D. A. Vorobiof ◽

C. Slabber ◽

G. Cohen ◽

A. S. Alberts ◽

...

Keyword(s):

Ovarian Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Platinum Sensitive

Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study

Annals of Oncology ◽

10.1093/annonc/mds052 ◽

2012 ◽

Vol 23 (10) ◽

pp. 2599-2605 ◽

Cited By ~ 5

Author(s):

R.P. Collea ◽

F.W. Kruter ◽

J.E. Cantrell ◽

T.K. George ◽

S. Kruger ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Pegylated Liposomal Doxorubicin

230 A Phase II Study of Pegylated Liposomal Doxorubicin Combined with Cyclophosphamide / 5-fluorouracil as Second Line Chemotherapy in Patients with Metastatic Breast Cancer Who Failed Previous Taxane-based Treatment

European Journal of Cancer ◽

10.1016/s0959-8049(12)70298-8 ◽

2012 ◽

Vol 48 ◽

pp. S109-S110

Author(s):

H.K. Chang ◽

Y.C. Lin ◽

K.M. Rau ◽

Y.Y. Chen ◽

K.D. Lee ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Second Line ◽

Second Line Chemotherapy ◽

Line Chemotherapy

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6602394 ◽

2005 ◽

Vol 92 (4) ◽

pp. 628-630 ◽

Cited By ~ 11

Author(s):

J W Valle ◽

A Dangoor ◽

J Beech ◽

D J Sherlock ◽

S M Lee ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Pegylated Liposomal Doxorubicin

Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.08.020 ◽

2006 ◽

Vol 100 (2) ◽

pp. 318-323 ◽

Cited By ~ 27

Author(s):

M.O. Nicoletto ◽

C. Falci ◽

D. Pianalto ◽

G. Artioli ◽

P. Azzoni ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Pegylated Liposomal Doxorubicin

Phase II study of combination therapy with liposomal doxorubicin and carboplatin in patients with previously untreated small cell lung cancer

10.1200/jco.2004.22.90140.7349 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7349-7349

Author(s):

B. L. Rapoport ◽

C. Slabber ◽

D. A. Vorobiof ◽

A. S. Alberts ◽

A. Uys

Keyword(s):

Lung Cancer ◽

Combination Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung

Feasibility phase II study of pegylated liposomal doxorubicin (PLD) and weekly paclitaxel-carboplatin (wTC), as first line therapy for patients with advanced ovarian carcinoma suboptimally debulked

10.1200/jco.2005.23.16_suppl.5139 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5139-5139

Author(s):

J. A. Arranz Arija ◽

R. González Beca ◽

A. Velasco ◽

P. Borrega ◽

I. Siso ◽

...

Keyword(s):

Ovarian Carcinoma ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Weekly Paclitaxel ◽

First Line ◽

Advanced Ovarian Carcinoma ◽

First Line Therapy ◽

Line Therapy

Bi-weekly administration of pegylated liposomal doxorubicin plus paclitaxel in metastatic breast cancer (MBC) patients: A phase II study

10.1200/jco.2005.23.16_suppl.844 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 844-844 ◽

Cited By ~ 2

Author(s):

E. Simoncini ◽

V. D. Ferrari ◽

V. Amoroso ◽

F. Valcamonico ◽

S. Grisanti ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Administration

Activity and toxicity of pegylated liposomal doxorubicin in combination regimen (DRCOP) for patients >60 years old with untreated diffuse large B cell lymphoma (DLBCL): A phase II study

10.1200/jco.2008.26.15_suppl.20505 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 20505-20505

Author(s):

M. A. Rodriguez ◽

M. Fanale ◽

F. B. Hagemeister ◽

P. McLaughlin ◽

B. Pro ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Combination Regimen ◽

Large B Cell Lymphoma ◽

Large B Cell